A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia

Psychiatry Research

Volumn 27, Issue 3, 1989, Pages 313-323

  Vaddadi, Krishna S ^a   Courtney, Paul ^a   Gilleard, Christopher J ^b   Manku, Mehar S ^c   Horrobin, David F ^c  

^a Crawley Hospital   (United Kingdom)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^c Efamol Limited   (Canada)

Author keywords

essential fatty acids; linoleic acid; memory; Schizophrenia; tardive dyskinesia

Indexed keywords

FATTY ACID;

ADULT; CLINICAL ARTICLE; HUMAN; MEMORY; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FATTY ACIDS, ESSENTIAL; FEMALE; HUMAN; MALE; MIDDLE AGE; PERSONALITY DISORDERS; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T;

EID: 0024602813     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(89)90146-7     Document Type: Article

References (28)

1. Effect of ADP on PGE formation in blood platelets from patients with depression, mania and schizophrenia
2. A comprehensive psychopathological rating scale
3. Essential fatty acids mean cell volume and nuclear magnetic resonance of ethanol-dependent human subjects
4. Effects of prostaglandins on chlorpromazine-induced catalepsy in mice
5. The antidyskinetic action of dihomogamma-linolenic acid in the rodent
6. Essential fatty acid requirements in pregnancy and lactation with special reference to brain development
7. Schizophrenia: Reconciliation of the dopamine, prostaglandin and opioid concepts and the role of the pineal
8. Essential fatty acids, prostaglandins, and alcoholism: An overview
9. Prostaglandins and schizophrenia: Further discussion of the evidence
10. In search of treatment for tardive dyskinesia: Review of the literature
11. 1 treatment of schizophrenia
12. Alpha-tocopherol in tardive dyskinesia
13. Fatty acids in plasma and red cell membranes in normal humans
14. Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linolenic acid
15. Problems in the dyskinesias
16. Asymmetrical transfer: An inherent weakness of repeated-measure drug experiments
17. 1-stimulated increases in cyclic AMP
18. 3H-dopamine continuously presented to rat brain in vivo
19. Tardive dyskinesias and essential fatty acids: An animal model study
20. Prostaglandin inhibition of apomorphine-induced circling in mice
21. A rating scale for tardive dyskinesia
22. Changes in fatty acid composition of human brain myelin lipids during maturation
23. Essential fatty acids and neuroleptic drug induced tardive dyskinesia—Preliminary clinical observations
24. 1 precursor in chronic neuroleptic-resistant schizophrenic patients
25. A standardized memory scale for clinical use
26. Essential fatty acid supplementation in tardive dyskinesia